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Abstract: Background: Osteoporosis is a condition in which the bones become brittle, increasing
the risk of fractures. Complementary medicines have traditionally used animal bones for managing
bone disorders, such as osteoporosis. This study aimed to discover new natural products for these
types of conditions by determining mineral and protein content of bone extracts derived from the
Australian wallaby. Methods: Inductively coupled plasma-mass spectrometry and Fourier transform
infrared spectroscopic analysis were used for mineral tests, proteome analysis was using LC/MS/MS
and the effects of wallaby bone extracts (WBE)s on calcium deposition and alkaline phosphatase
activity were evaluated in osteogenic cells derived from adipose tissue-derived stem cells (ADSCs).
Results: Concentrations of calcium and phosphorus were 26.21% and 14.72% in WBE respectively.
Additionally, minerals found were wide in variety and high in concentration, while heavy metal
concentrations of aluminium, iron, zinc and other elements were at safe levels for human consumption.
Proteome analysis showed that extracts contained high amounts of bone remodelling proteins,
such as osteomodulin, osteopontin and osteoglycin. Furthermore, in vitro evaluation of WBEs
showed increased deposition of calcium in osteoblasts with enhanced alkaline phosphatase activity
in differentiated adipose-derived stem cells. Conclusion: Our results demonstrate that wallaby bone
extracts possess proteins and minerals beneficial for bone metabolism. WBEs may therefore be used
for developing natural products for conditions such as osteoporosis and further investigation to
understand biomolecular mechanism by which WBEs prevent osteoporosis is warranted.
Keywords: wallaby bone; mineral components; protein components; bone remodelling
proteins; osteoporosis
1. Introduction
Osteoporosis is a medical condition in which the bones become brittle and fragile from a loss of
tissue, typically as a result of hormonal changes or deficiency in calcium or vitamin D [1]. This increases
the likelihood of complications such as fractures, which most commonly occur in the spine, wrist and
hips, but can also affect the arm or pelvis. According to the International Osteoporosis Foundation
(IOF), it is estimated that there are approximately 200 million osteoporosis patients worldwide, with
a particularly high prevalence in females and the elderly [2]. In Australia, not only is there an aging
population, but also relatively high rates of vitamin D deficiency. Moreover, osteoporosis heavily
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contributes to hospitalisation and related expenses costing approximately $1.9 billion per annum [3].
Preventative treatment of osteoporosis and related fractures for high risk groups is important. Therefore
it is necessary to develop products suitable for long-term use [4–6]. A promising source of natural
products for osteoporosis commonly uses plant-based agents such as marine plants and soybean
products, which are rich in protein and calcium. Recently, the contents of animal bones have become
of interest, with research into as many as 17 animals, including sika deer, red deer, pig, sheep, dog, and
cow [7]. The bone extracts from these animals may contain active minerals and proteins such as Bone
Morphogenetic Proteins (BMPs) that could positively impact bone and fat metabolism. Despite this,
research at this stage is primarily observational with more investigation needed for the mechanisms of
action of the active ingredients of these bone products.
The wallaby is an active, lean and wild animal unique to Australia, with over sixty different
species. It is estimated that the four most common species of wallaby are numerically in excess of
50 million animals [8,9]. At present, the wallaby industry relies heavily on producing wallaby meat [10],
while the bones are considered to be a waste product. For these reasons, we hypothesised that wallaby
bone extracts may be a potentially efficacious treatment option for osteoporosis. In this study we
aimed to identify and quantify the ingredients (mineral and protein) of wallaby bone extracts while
also identifying the calcium to phosphorus ratio and heavy metal content. This was achieved by using
inductively coupled plasma-mass spectrometry (ICP-MS) and Fourier transform infrared spectroscopy
(FT-IR) spectroscopic analysis. Alongside this, liquid chromatography-mass spectrometry (LC-MS/MS)
was used to perform proteomics analyses, which further clarified the wallaby bone protein composition
and putative functions.
To our knowledge, this is the first scientific evaluation of Australian wallaby bone extracts using
a Systems Biology approach, and may lead to the discovery of a potential alternative therapy for the
treatment and prevention of osteoporosis.
2. Material and Methods
2.1. Animal and Bone Samples
Bennett’s wallaby Macropus rufogriseus, mixed genders, were harvested from Tasmanian farmlands
in Australia. The fresh femur, tibia and fibula bones were collected and supplied by Lenah Game
Meats. The bones of three individual wallabies were used in the physical testing and analysis processes.
In brief, after harvesting, fresh bones were trimmed free of soft tissue and washed with cold phosphate
buffer saline (PBS) to remove contaminants, wrapped with gauze pre-soaked in PBS containing a
protease inhibitor cocktail, then stored at −20 ◦C overnight. Ten grams of the parietal bone fragments
(about 10 mm × 1 mm size, 1 to 2 mm thick, n = 3) were frozen in liquid nitrogen and then ground up
using a mortar and pestle for subsequent chemical analysis and protein determination [11].
2.2. Digestion Procedures for Wallaby Bone
Wallaby bone samples which contained fibula, femur and tibia bone specimens were dried
overnight and weighed (about 0.150 g). The dried samples were then placed into a 15-mL Falcon
tube (Fisher Scientific, Sydney, NSW, Australia). Optima grade nitric acid (0.8 M, 3 mL) and ultrapure
hydrogen peroxide (30%, 1 mL) were then added to the tubes and capped. The tubes were placed
on a hot plate at 45 ◦C for one hour. The temperature was then increased to 80 ◦C for 12 h. The final
solution was quantitatively transferred to 50 mL plastic centrifuge tubes (Fisher Scientific, Sydney,
NSW, Australia) and filled to the mark with ultrapure deionized water (>18 MΩ·cm−1) and weighed.
2.3. Inductively Coupled Plasma-Mass Spectrometry
The ICP-MS system (Agilent Technologies 7500cx series, Santa Clara, CA, USA) was used with
sample introduction via a micromist concentric nebuliser (Glass expansion, Port Melbourne, VIC,
Australia) and a Scott type double pass spray chamber cooled to 2 ◦C. The sample solution and the
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spray chamber waste were carried with the aid of a peristaltic pump (Watson-Marlow, Wetherill Park,
NSW, Australia). ICP-MS extraction lens conditions were selected to maximise the sensitivity of a
1% HNO3:HCl solution containing 1 ng/ml of lithium, cobalt, yttrium, cerium and thallium. Helium
was added into the octopole reaction cell to reduce interferences. Calibration curves were constructed
and the results analysed using Masshunter software (version 2014, Agilent Technologies, Santa Clara,
CA, USA).
A certified calibration standard containing lithium (Li), beryllium (Be), boron (B), sodium (Na),
magnesium (Mg), aluminium (Al), calcium (Ca), vanadium (V), chromium (Cr), manganese (Mn),
iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), zinc (Zn), arsenic (As), selenium (Se), strontium (Sr),
molybdenum (Mo), silver (Ag), cadmium (Cd), antimony (Sb), barium (Ba), lanthanum (La), europium,
(Eu), holmium (Ho), ytterbium (Yb), thallium (Tl), lead (Pb), bismuth (Bi), thorium (Th), uranium (U),
phosphorus (P) andmercury (Hg) standard was obtained from Choice Analytical, (Thornleigh, NSW,
Australia). Baseline nitric acid (HNO3) and hydrogen peroxide (H2O2) were purchased from Choice
Analytical (Thornleigh, NSW, Australia).
2.4. Fourier Transform Infrared Spectroscopy
FT-IR was carried out using a Thermo Scientific Nicolet 6700 spectrometer (Waltham, MA,
USA).with a DTGS (Deuterated Tri Glycine Sulfate) (Waltham, MA, USA) detector. The powder
samples were dispersed in Potassium Bromide discs and all spectra were obtained using 4 cm−1
resolution and 64 scans at room temperature.
2.5. Protein Extraction from Wallaby Bone
The protein extraction process is summarised in Figure 1. Bone fragments (3× 3 g) were incubated
in 1.2 M HCl (10 mL for each sample) at 4 ◦C overnight to demineralise bone tissue. The supernatant
was collected as Extract 1 (E1) after centrifugation at 4000 rpm for 15 min at 4 ◦C. The pelleted material
was washed with water and extracted for 72 h at 4 ◦C in a lysis buffer containing 8 M urea, 100 mM
Tris-HCl (pH 8.8) and a protease inhibitor cocktail. The supernatant was then collected as Extract 2
(E2) after centrifugation. The pelleted material was extracted further for 72 h at 4 ◦C in a lysis buffer
containing 8 M urea, 100 mM Tris-HCl, 0.5 M tetrasodium EDTA (pH 8.8) and a protease inhibitor
cocktail. The supernatant was collected as Extract 3 (E3) after centrifugation. Finally, the remaining
pellet was incubated in 6 M HCl overnight at 4 ◦C. The solution was collected as Extract 4 (E4) after
centrifugation [12]. The acidic extracts were neutralised and the pH adjusted to ~ 8.
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2.6. Protein Determination with Bradford Assay Kit
Disulfide bonds in the protein samples were reduced using dithiothreitol (20 mM final
concentration, Bio-Rad, Hercules, CA, USA). The samples were then incubated at room temperature
for 45 min, before alkylation with acrylamide monomers (20 mM final concentration, Bio-Rad), and
then incubated at room temperature for 45 min. The protein was precipitated by adding 5 volumes of
acetone (1:5, v/v). After centrifugation, the pellet was resuspended with a minimum volume of 8 M
urea, 100 mM NH4HCO3 using a sonic probe. Protein concentrations in the four extracts of individual
wallaby femur, tibia and fibula were determined using the Bradford assay kit (Bio-Rad).
2.7. Protein Concentration Assay by SDS-PAGE System
The protein concentrations of E1, E2, E3 and E4 samples were ascertained using SDS-PAGE.
Samples diluted to 1:10 and 1:50 and a serial dilution of albumin (1 mg/mL) were mixed with Laemelli
sample Buffer (Bio-Rad). Forty microliters of each sample was loaded onto 26-well Criterion™ TGX™
Precast Gels (Bio-Rad), and run at 160 V for 3 min. The gel was fixed and then stained with Flamingo™
Fluorescent stain (Bio-Rad). The density of bands was quantified using Quantity One software (v4.6.1,
Bio-Rad) based on the BSA standard curve.
The E4 sample contained salt which was subsequently removed using Bio-spin 6 chromatography
columns (Bio-Rad), and then dilutions using ratios of 1:2, 1:4 and 1:8 were carried out on the E4 sample
and subjected to SDS = PAGE which showed the salt had been removed.
Approximately 100 µg of protein was diluted with 50 mM NH4HCO3 to adjust the urea
concentration to 1 M. Trypsin (1 µL, MS grade, 1 µg/µL, Sigma-Aldrich, St. Louis, MO, USA) was
added to each tube, and the sample tubes were incubated overnight at 37 ◦C. The digested samples
were centrifuged at maximum speed for 5 min prior to solid phase extraction using HLB columns
(Silicycle®, Quebec, QC, Canada) to recover the peptides. Samples were concentrated to approximately
15 µL (E1), or 25 µL (E2, E3 and E4).
2.8. Liquid Chromatography–Mass Spectrometry (LC-MS/MS)
Using an Eksigent AS-1 autosampler connected to a Tempo nanoLC system (Eksigent, Dublin, CA,
USA) as previously described [13], 10 µL of each combined extract sample was loaded at 20 µL/min
with MS buffer A (2% Acetonitrile + 0.2% Formic Acid) onto a C8 trap column (Michrom Bioresources,
Auburn, CA, USA). After washing the trap for three min, the peptides were washed off the trap
at 300 nL/min onto a PicoFrit column (75 µm ID × 150 mm; New Objective, Woburn, MA, USA)
packed with Magic C18AQ resin (Michrom Bioresources, Auburn, CA, USA), then eluted from the
column and into the source of a QSTAR Elite hybrid quadrupole-time-of-flight mass spectrometer
(AB Sciex, Eksigent, Dublin, CA, USA) using the following program [14,15]: 5%–30% MS buffer B
(98% acetonitrile + 0.2% formic acid) over 60 min, 30%–80% MS buffer B over 3 min, 80% MS buffer
B for 2 min, 80%–85% for 3 min. The eluting peptides were ionised at 2300 V. An Intelligent Data
Acquisition (IDA) experiment was performed, with a mass range of 350–1500 Da continuously scanned
for peptides of charge state 2+–5+ with an intensity of more than 30 counts/s. The selected peptides
were fragmented and the product ion fragment masses measured over a mass range of 100–1500 Da.
The mass of the precursor peptide was then excluded for 120 s.
2.9. MS/MS Data Analysis and Protein Identification
The MS/MS data files produced were searched using Mascot Daemon (version 2.4; Perkins,
D.N. 1999, Boston, MA, USA) against the LudwigNR database (comprised of the UniProt, plasmoDB
and Ensembl databases, vQ213) with the following parameter settings: Fixed modifications: none;
Variable modifications: propionamide, oxidised methionine and deamidated asparagine; Enzyme:
semitrypsin; Number of allowed missed cleavages: 3; Peptide mass tolerance: 100 ppm; MS/MS
mass tolerance: 0.2 Da; Charge state: 2+, 3+ and 4+. The results of the search were then filtered by
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including only protein hits with at least one unique peptide (Bold Red) and excluding peptide hits with
a p-value greater than 0.05. Peptides identified by the Mascot were further validated using Scaffold
(v4.0, Proteome Software, Portland, OR, USA) and by manual inspection of the MS/MS spectra for
the peptide to ensure the b- and y-ion series were sufficiently extensive for an accurate identification.
Peptide identifications were accepted if they could be established at a probability greater than 95.0% as
specified by the Peptide Prophet algorithm [16]. Protein identifications were accepted if they could be
established at probability greater than 80.0% as assigned by the Protein Prophet algorithm [17].
2.10. In Vitro Evaluation of Wallaby Bone Extracts on Osteogenic Elements
To determine beneficial effect of wallaby bone extracts (WBE) on bone metabolism, osteogenic
elements of calcium (Ca) and alkaline phosphatase (ALP) activity were measured in osteogenic
cells derived from adipose tissue-derived stem cells (ADSCs) with and without WBE treatment.
In brief, WBEs (1, 5 and 10 µg/mL) were added into Dulbecco's Modified Eagle Medium (DMEM)
Glutmax/F12 (Gibco®, Waltham, MA, USA) medium containing 0.1 µM dexamethasone, 50 µM
ascorbate-2-phosphate, 10 mM β-glycerophosphate and 10% foetal bovine serum during 14 days of
human ADSCs differentiation into osteogenic cells, as previously described [18], and culture medium
treatment as a control. At the end of the experiment, WBEs treated cells with the control cells were
harvested for determination of amount of calcium and ALP activity. In brief, cell samples were
completely lysed by sonication and the supernatants were collected for measuring amount of calcium
and the ALP activity using the automatic biochemistry instrument (ARCHITECT, Abbot Park, IL, USA)
according to manufacturer’s instruction.
2.11. Statistical Analysis
Quantitative data is expressed as the mean ± SEM. Comparisons across the four groups were
done using one-way ANOVA, followed by a post hoc analysis of Tukey’s test to determine significant
differences between the two groups, using Prism version 4 (Graph Pad Inc., San Diego, CA, USA).
In this process, a p-value < 0.05 was considered statistically significant.
3. Results
3.1. Mineral Analysis
All mineral analyses were conducted in triplicate. The results of the major component analysis
are shown in Table 1. The concentrations of moisture, calcium and phosphorus from wallaby bone are
41.24%, 26.21% and 14.72%, respectively.
Table 1. Quantity of major components in wallaby bones.
Bone Samples Water (%) Ca (%) p (%)
Femur 54.44 ± 4.09 22.72 ± 8.14 12.36 ± 4.46
Fibula 34.05 ± 5.90 27.54 ± 1.46 16.47 ± 6.24
Tibia 35.23 ± 6.34 27.33 ± 3.16 14.92 ± 1.16
Average 41.24 ± 11.45 26.21 ± 6.87 14.72 ± 4.64
Results show different bone parts (femur, fibula and tibia) derived from three individual wallaby samples (n = 3).
There is a wide variety of mineral elements at moderate levels in wallaby bone (Table 2), the
magnesium content is 870 mg/kg, which is good for magnesium supplementation, and other mineral
elements assayed include aluminium, iron, strontium, zinc, barium at 264.44 mg/kg, 151.59 mg/kg,
559.19 mg/kg, 76.94 mg/kg, 88.91 mg/kg, respectively, the contents of which are high and rich.
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Table 2. Quantity of medium level minerals in wallaby bones.
Bone Samples
Na Mg Al Fe Sr Ba
(mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg)
Femur 5.48 × 104 ± 0.53 0.99 × 103 ± 0.03 238.77 ± 22.99 135.04 ± 3.08 495.00 ± 15.71 89.16 ± 13.54
Fibula 5.16 × 104 ± 0.24 0.78 × 103 ± 0.14 292.71 ± 13.37 166.64 ± 1.38 611.83 ± 23.96 92.96 ± 14.00
Tibia 4.40 × 104 ± 0.81 0.83 × 103 ± 0.05 261.84 ± 14.85 153.08 ± 4.00 570.75 ± 11.59 84.62 ± 9.10
Average 5.01 × 104 ± 1.55 0.87 × 103 ± 0.21 264.44 ± 27.06 151.59 ± 15.85 559.19 ± 59.26 88.91 ± 4.18
Results show different bone parts (femur, fibula and tibia) derived from three individual wallaby samples (n = 3).
According to the European Medicines Agency standards, and the Committee for Medicinal
Products for Human Use (CHMP) [19], all of the heavy metal concentrations from kangaroo bone are
below the human prescribed standards (Table 3). Of importance, the level of arsenic was below the
detection limit [20]. However, not all heavy metals have negative effects. For example, copper, iron,
zinc, manganese and other elements are essential trace elements to human health because they are
not only the main ingredient of anti-free radical substances in the human body, and have anti-ageing
effects [21], but also co-factors in various important metalloenzymes and other metalloproteins, such
as hemeproteins (haemoglobin, cytochromes etc.) [22,23].
Table 3. Quantity of heavy metals and micro minerals in wallaby bones.
Bone Samples
Pb Ni Mn Cu Cr Se Zn
(mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg)
Femur 0.15 ± 0.01 3.97 ± 0.86 1.31 ± 0.21 1.11 ± 0.33 1.08 ± 0.19 0.71 ± 0.03 71.65 ± 5.52
Fibula 0.41 ± 0.01 1.36 ± 0.45 2.82 ± 0.36 1.84 ± 1.13 1.30 ± 0.25 0.76 ± 0.04 81.74 ± 6.46
Tibia 0.16 ± 0.08 0.05 ± 0.02 1.31 ± 0.24 1.12 ± 0.90 0.09 ± 0.05 0.69 ± 0.05 77.44 ± 8.27
Average 0.24 ± 0.15 1.79 ± 1.99 2.11 ± 0.76 1.36 ± 0.42 0.82 ± 0.64 0.72 ± 0.12 76.94 ± 5.06
Results show different bone parts (femur, fibula and tibia) derived from three individual wallaby samples (n = 3).
A recent medical study has shown that copper deficiency can lead to bone mineralization disorders
and cause senile osteoporosis. Furthermore, it found that iron is an important component of red blood
cells that plays an essential role in haematopoiesis. The use of iron supplementation from wallaby
bones may prevent iron deficiency anaemia [24].
Manganese and zinc not only play an active role in normal growth, but are also very important to
other biological activities; manganese is involved in haematopoiesis, oxidation, reduction, calcium
and phosphorus metabolism, bone formation, and the growth and development of body function [25].
Zinc is also a key factor for a healthy immune system.
Therefore, the development of a wallaby bone supplement could offer a simple and effective
alternative to calcium and magnesium supplementation, and address damage to the human body
caused by a lack of these minerals.
3.2. Organic Compounds Analysis
FT-IR spectroscopy was used to measure bulk biochemical characteristics of the meat-and
bone-based samples and also provided a check on contamination of the products by organic
compounds. The FT-IR spectrum of wallaby bone is shown in Figure 2.
The bands from the mineral component (mostly carbonate and phosphate apatite groups) are
those representing phosphate groups at about 1100–950 and 600–550 cm−1 (phosphate ν1, ν3 and ν4
respectively) and carbonate groups at about 875 and 1500–1400 cm−1 (the ν2 and ν3 vibrational modes
respectively). These spectra are consistent with those of normal bone samples.
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Figure 2. The FTIR spectrum of wallaby bone shows bands originating from protein (mostly amide
C=O groups: these include the amide I band at about 1653 cm−1, the amide II band at about 1540 cm−1
and the amide III band about 1238 cm−1) and lipids (e.g., C–H vibrations at about 2923, 2852 and 1744 cm−1).
3.3. Total Protein Content from Four Protein Extracts in Different Bone Samples
To determine the different protein concentrations from the four different extracts from bone
samples, 40 extraction samples were collected together and tested using the Bradford assay kit (Bio-rad
Laboratories, Hercules, CA, USA) at the same time as the first protein determination. Total protein
content of four protein extracts from different types of bone samples was shown in Table 4.
Table 4. Total protein content of protein extracts (mg/g of bone) from different types of bone.
Bone Protein Extracts Femur (mg/g) Tibia (mg/g) Fibula (mg/g)
Extract 1 0.709 ± 0.07 0.611 ± 0.08 0.236± 0.03
Extract 2 0.922 ± 0.04 0.718 ± 0.04 0.305 ± 0.02
Extract 3 0.152 ± 0.02 0.092 ± 0.02 0.008 ± 0.05
Extract 4 0.70 ± 0.04 0.787 ± 0.05 0.613 ± 0.01
Total 2.48 ± 0.1.36 2.21 ± 0.11 1.23 ± 0.13
3.4. Identification of Peptides and Proteins by Proteome Analysis
According to the volume loaded into the LC/MS/MS instrument, the quantity of peptide present
was 5 µg for each extract. The filtering criterion was set at 95.0% minimum Peptide Thresholds and
the false-positive prophet rate was 0.58%. For the uniquely identified proteins, the filtering criterion
was 50.0% minimum 1 min peptides and the false-discovery rate was 2.4% and the peptides and
proteins were identified with high confidence. The number of unique peptides and unique proteins
from the four extractions are listed in Table 2. E4 contained 481, 417 and 137 unique spectra, peptides
and proteins, respectively, as seen in Table 5 and Figure 3, which was the highest amount among the
extractions. However, previous studies have suggested that prolonging the instrument acquisition
time and the loading volume may have produced different results [12,15].
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The quantity of protein extracted, number of peptides and proteins identified from the four protein extracts
were identified using the sequential extraction protocol by auto-searching with Scaffold software.
3.5. Biological Process Classification of the Identified Proteins
A total of 171 identified proteins (83.0%) were classified into biological process categories. These
classifications were based on common gene ontology terms and can be seen in Figure 4. The bone
remodelling proteins found within these categories include osteomodulin, osteopontin, osteoglycin,
osteocalcin, bone sialoprotein 2 and decorin.
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3.6. Cellular Component of the Identified Proteins
A total of 60 identified proteins (29.1%) were classified as cellular components, the cellular
components from individual sample extractions are classified as shown in Figure 5. The highest
proportion of identified proteins was found in the intracellular organelle, amounting to 16%–21%.
In descending order, the proteins were found in the extracellular region (13.5%–18.5%), the organelle
(13.5%–18.5%), the cytoplasm (10%–16.5%) and the cytoskeleton (6.5%–9.8%).
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3.7. Protein Role Assignment of the Identified Proteins
A total of 178 identified proteins (86.4%) were classified according to protein function.
The classification of identified proteins from the individual sample extractions according to molecular
function is shown in Figure 6. This graph shows the identified proteins based on their known
physiological functions. The interesting thing found here was that there were only two main groups
were detected; binding group (77%–80%) and molecular function group (87%–90%) as shown in
Figure 6. The only other minor group detected was structural molecule activity group (12%–14%) with
the rest of the groups were lower than 10%, as seen in Figure 6.
The molecular function group had the largest number of proteins identified. This broad category
contained many proteases and enzymes involved in the stimulation and proliferation of bone cells.
This important discovery will be the main focus of our further study. The second largest number of
proteins was present in the binding function group.
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3.8. Calcium Concentration and Alkaline Phosphate Activity in WBE Treated Osteogenic Cells
The calcium concentrations were significantly higher by 3.0-, 3.1- and 3.7-fold, respectively,
in WBE treated cells compared to the control cells (Figure 7A) but only high dose of WBE treatment
(10 µg/mL) enhanced ALP activity (Figure 7B).
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In addition, wallaby bone contains high levels of other essential minerals with heavy metal 
concentrations below the human prescribed standard. 
Table 6. Average of major component in wallaby bones compared with the bones of domestic animals. 
Bone Samples Water (%) Ca(%) p (%)
Wallaby bone 41.24 26.21 14.72 
Alpaca Bone 41 20 8.8 
Beef Bone 64.2 5.1 2 
Pork Bone 66.7 4.5 2.2 
Lamb Bone 65.1 3.4 1.6 
Chicken Bone 65.6 1 0.5 
Figure 7. Calcium content (A) and ALP activity (B) in osteogenic cells derived from adipose
tissue-derived stem cells (ADSCs) with wallaby bone extracts (WBE) treatments (1, 5 and 10 µg/mL).
Data from three separate experiments, * p < 0.05 and ** p < 0.01 vs. control.
4. Discussion
Fro the che ical analysis of allaby bone, the minerals analysis showed that there was not
a significant difference between the femur, fibula and tibia samples (Table 3). When these results
are compared with other domestic animals’ bone, the concentrations of calcium and phosphorus in
allaby bone are significantly higher than in alpaca bone, beef bone, pork bone, lamb bone and chicken
bone (Table 6) previously reported [21,26]. The most interesting finding is the 2:1 ratio of calcium
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and phosphorus in wallaby bone, which is similar to the calcium to phosphorus ratio in human bone.
This ratio may make the substance of wallaby bone readily absorbed for consumption. In addition,
wallaby bone contains high levels of other essential minerals with heavy metal concentrations below
the human prescribed standard.
Table 6. Average of major component in wallaby bones compared with the bones of domestic animals.
Bone Samples Water (%) Ca (%) p (%)
Wallaby bone 41.24 26.21 14.72
Alpaca Bone 41 20 8.8
Beef Bone 64.2 5.1 2
Pork Bone 66.7 4.5 2.2
Lamb Bone 65.1 3.4 1.6
Chicken Bone 65.6 1 0.5
Protein analysis has revealed that the femur contains the highest amount of protein. Extract 4
from each type of bone had the highest amount of protein among the four extracts. This result matched
the protein identification results from the LC/MS/MS. A total number of 2038 spectra, 206 unique
proteins and 137 clusters were identified. The analysis of Extract 4 also presented the largest number
of spectra, peptides and proteins. When the proteins from the extracts were classified according to
cellular component, biological process and protein role assignment, the largest component of the four
extractions was also Extract 4 among groups; this was consistent with the protein assay.
These results may be attributed to a high abundance of proteins or protein fragments existing
in this fraction (Extract 4) that may suppress the identification of other proteins [12]. Additionally,
among those 206 unique proteins identified, up to 65 (31.6%) were found in all four extracts, while 4
(1.9%) proteins in Extract 1, 7 (3.3%) proteins in Extract 2, 11 (5.3%) proteins in Extract 3, and 54 (26.2%)
proteins in Extract 4 were uniquely observed (Figure 3). Even the amount of overlap between proteins
that had been identified was quite high in the fractions from different extraction steps. The different
extraction methods (Extracts 1 to 4) still have a lot of unique proteins, particularly Extract 4.
The most interesting results found in the gene ontology and cell function groups of those identified
proteins were that the major components included proteases and enzymes involved in the stimulation
and proliferation of bone cells. Normally, the non-collagenous proteins only make up 10% of total
bone protein content, while a majority of the biologically important proteins are naturally relatively
low. However, in the proteome analysis study, we found that the cellular process and organismal
process proteins of biological process classification were identified up to 69% and 54%, respectively,
indicating that high amounts of bone remodelling proteins, like osteomodulin, osteopontin, osteoglycin,
osteocalcin, bone sialoprotein-2 and decorin may exist in wallaby bone.
This study was designed mainly to characterize bone beneficial components from Australian
Wallaby bone but the in vitro evaluation of wallaby bone extracts in the differentiation of ADSCs into
osteogenic cells showed the WBEs increased deposition of calcium in osteoblasts with enhanced ALP
activity at a high dose. In increased ALP activity and total calcium concentration by the nutrients have
demonstrated the positive effects on the homeostasis of bone [27]. Although more investigation is
required, these data highlights a view of the future study on WBE as supplements to prevent or treat
bone disorder, such as osteoporosis and bone fracture.
Overall, the results of mineral and protein analysis suggest that substance from Australian wallaby
bone may have potential to be beneficial for mineral deficiency related to osteoporosis. Future studies
using an animal model of osteoporosis to investigate the therapeutic effect of wallaby bone extract on
bone formation, differentiation and proliferation is warranted.
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